The test, run on Abbott's portable i-STAT® Alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mTBI), or concussion The test produces ...
Abbott, a healthcare company focused on the development, manufacturing and marketing of pharmaceuticals and medical products, will collaborate with Genetics Laboratory on developing a diagnostic test ...
Editor’s Note: This article originally appeared on Abbott’s website. ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the launch of its Afinion™ 2 analyzer in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results